The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling

Progress in Neurobiology

Volumn 56, Issue 5, 1998, Pages 541-569

  Roßner, Steffen ^a   Ueberham, Uwe ^a   Schliebs, Reinhard ^a   Regino Perez Polo, J ^b   Bigl, Volker ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; MUSCARINIC M1 RECEPTOR; MUSCARINIC M3 RECEPTOR; NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; NEUROTROPHIN RECEPTOR; PROTEIN KINASE C;

ALZHEIMER DISEASE; BRAIN MATURATION; CHOLINERGIC NERVE CELL; FOREBRAIN; HUMAN; HUMAN CELL; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM; PROTEIN PROCESSING; REVIEW;

ACETYLCHOLINE; ALZHEIMER DISEASE; AMYLOID; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; BASAL GANGLIA; BRAIN; CHOLINERGIC AGONISTS; HUMANS; ISOENZYMES; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; MULTIGENE FAMILY; NERVE GROWTH FACTORS; PROTEIN KINASE C; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, NERVE GROWTH FACTOR; RECEPTOR, TRKA; RECEPTORS, CHOLINERGIC; RECEPTORS, MUSCARINIC; RECEPTORS, NERVE GROWTH FACTOR; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 0001059974     PISSN: 03010082     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0301-0082(98)00044-6     Document Type: Review

References (385)

1. Abraham C. R., Selkoe D. J., Potter H. Immunochemical identification of the serine protease inhibitor alpha-1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell. 52:1988;487-501.
2. Alberch J., Carman-Krzan M., Fabrazzo M., Wise B. C. Chronic treatment with scopolamine and physostigmine changes nerve growth factor (NGF) receptor density and NGF content in rat brain. Brain Res. 542:1991;233-240.
3. Anderson A. J., Su J. H., Cotman C. W. DNA damage and apoptosis in Alzheimer's disease: colocalization with c-jun immunoreactivity, relationship to brain area and effect of postmortem delay. J. Neurosci. 16:1996;1710-1719.
4. Anderson J. P., Esch F. S., Keim P. S., Sambamurti K., Lieberburg I., Robakis K. Exact cleavage site of Alzheimer amyloid precursor protein in neuronal PC12 cells. Neurosci. Lett. 128:1991;126-128.
5. Apelt J., Schliebs R., Beck M., Roßner S., Bigl V. Expression of amyloid precursor protein mRNA isoforms in rat brain is differentially regulated during postnatal maturation and by cholinergic activity. Int. J. Dev. Neurosci. 15:1997;95-112.
6. Araujo D. M., Lapchak P. A., Robitaille Y., Gauthier S., Quirion R. Differential alteration of various cholinergic markers in cortical and subcortical regions of human brain in Alzheimer's disease. J. Neurochem. 50:1988;1914-1923.
7. Arendt T., Bigl V., Arendt A., Tennstedt A. Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's disease. Acta Neuropath. 61:1983;101-108.
8. Arendt T., Bigl V., Tennstedt A., Arendt A. Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's disease. Neuroscience. 14:1985;1-14.
9. Arendt T., Zvegintseva H. G., Leontovich T. A. Dendritic changes in the basal nucleus of Meynert and in the diagonal band nucleus in Alzheimer's disease - a quantitative Golgi study. Neuroscience. 19:1986;1265-1278.
10. Arendt T., Brückner M. K., Bigl V., Marcova L. Dendritic reorganization in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's disease. J. Comp. Neurol. 351:1995;189-222.
11. Arriagada P. A., Growdon J. H., Hedley-White E. T., Hyman B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology. 42:1992;631-639.
12. Auld D. S., Kar S., Quirion R. β-amyloid peptides as direct cholinergic neuromodulators: a missing link? Trends Neurosci. 21:1998;43-49.
13. Ayer-LeLievre C., Olson L., Ebendal T., Seiger A., Persson H. Expression of β-nerve growth factor gene in hippocampal neurons. Science. 240:1988;1339-1341.
14. LNTR reduces NGF binding to TrkA on PC12 cells. Neuron. 13:1994;203-215.
15. Bartoo G. T., Nochlin D., Chang D., Kim Y., Sumi S. M. The mean Aβ load in the hippocampus correlates with duration and severity of dementia in subgroups of Alzheimer's disease. J. Neuropath. Exp. Neurol. 56:1997;531-540.
16. Bartus R. T., Dean R. L., Beer B., Lippa A. S. The cholinergic hypothesis of geriatric memory dysfunction. Science. 217:1982;408-417.
17. Baxter M. G., Bucci D. J., Gorman L. K., Wiley R. G., Gallagher M. Selective immunotoxic lesions of basal forebrain cholinergic cells: effects on learning and memory in rats. Behav. Neurosci. 109:1995;714-722.
18. Berger-Sweeney J., Heckers S., Mesulam M. M., Wiley R. G., Lappi D. A., Sharma M. Differential effects on spatial navigation of immunotoxin-induced cholinergic lesions of the medial septal area and nucleus basalis magnocellularis. J. Neurosci. 14:1994;4507-4519.
19. Bickel U., Kewitz H. Colocalization of choline acetyltransferase and nerve growth factor receptor in rat basal forebrain. Dementia. 1:1990;146-150.
20. Bigl M., Eschrich K. Interaction of rat brain phosphofructokinase with Alzheimer's βA4-amyloid. Neurochem. Int. 26:1995;69-75.
21. Bigl V., Woolf N. J., Butcher L. L. Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis. Brain Res. Bull. 8:1982;727-749.
22. Blessed G., Tomlinson B. E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br. J. Psychiat. 114:1968;798-811.
23. Book A. A., Wiley R. G., Schweitzer J. B. Specificty of 192IgG-saporin for NGF receptor-positive cholinergic basal forebrain neurons in the rat. Brain Res. 590:1992;350-355.
24. Book A. A., Wiley R. G., Schweitzer J. B. 192IgG-saporin: I. Specific lethality for cholinergic neurons in the basal forebrain of the rat. J. Neuropathol. Exp. Neurol. 53:1994;95-102.
25. Borchelt D. R., Thinakaran G., Eckman C. B., Lee M. K., Davenport F., Ratovitsky T., Prada C. M., Kim G., Seekins S., Yager D., Slunt H. H., Wang R., Seeger M., Levey A. I., Gandy S. E., Copeland N. G., Jenkins N. A., Price D. L., Yankner S. G. Familial Alzheimer's disease-linked presenilin-1 variants elevate Aβ 1-42/1-40 ratio in vitro and in vivo. Neuron. 17:1996;1005-1013.
26. Bowen D. M., Smith C. B., White P., Davison A. N. Neurotransmitter-related enzymes indices of hypoxia in senile dementias and other abiotrophies. Brain. 99:1976;459-496.
27. Braak H., Braak E. Neuropathological stageing of Alzheimer's related changes. Acta Neuropathol. 82:1991;239-259.
28. Braak H., Braak E., Yilmazer D., de Vos R. A. I., Jansen E. N. H., Bohl J. Pattern of brain destruction in Parkinson's disease and Alzheimer's disease. J. Neural. Transm. 103:1996;455-490.
29. Breen K. C. APP-collagen interaction is mediated by a heparin bridge mechanism. Mol. Chem. Neuropathol. 16:1992;109-121.
30. Breen K. C., Bruce M., Anderton B. H. β-amyloid precursor protein mediates neuronal cell-cell and cell-surface adhesion. J. Neurosci. Res. 28:1991;90-100.
31. Buckley N. J., Bonner T. I., Buckley C. M., Brann M. R. Antagonist binding properties of five cloned muscarinic receptors expressed in CHO-K1 cells. Mol. Pharmacol. 35:1989;469-476.
32. Busciglio J., Gabuzda D. H., Matsudaira P., Yankner B. A. Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. natl Acad. Sci. U.S.A. 90:1993;2092-2096.
33. Bush A. I., Multhaup G., Moir R. D., Williamson T. G., Small D. H., Rumble B., Pollwein P., Beyreuther K., Masters C. L. A novel zinc (II) binding site modulates the function of the beta-A4 amyloid protein precursor of Alzheimer's disease. J. Biol. Chem. 268:1993;16109-16112.
34. Buxbaum J. D., Gandy S. E., Cicchetti P., Ehrlich M. E., Czernik A. J., Fracasso R. P., Ramabhadran T. V., Unterbeck A. J., Greengard P. Processing of Alzheimer β/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc. natl Acad. Sci. U.S.A. 87:1990;6003-6006.
35. Buxbaum J. D., Oishi O., Chen H. I., Pinkas-Kramarski R., Jaffee E. A., Gandy S. E., Greengard P. Cholinergic agonists and interleukin-1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proc. natl Acad. Sci. U.S.A. 89:1992;10075-10078.
36. Buxbaum J. D., Koo E. H., Greengard P. Protein phosphorylation inhibits production of Alzheimer amyloid β/A4 peptide. Proc. natl Acad. Sci. U.S.A. 90:1993;9195-9198.
37. NGFR-associated protein kinase. EMBO J. 15:1996;3369-3376.
38. Caporaso G. L., Gandy S. E., Buxbaum J. D., Ramabhadran T. V., Greengard P. Protein phosphorylation regulates secretion of Alzheimer β/A4 amyloid precursor protein. Proc. natl Acad. Sci. U.S.A. 89:1992;3055-3059.
39. Caporaso G. L., Takei K., Gandy S. E., Matteoli M., Mundigl O., Greengard P., De Camilli P. Morphologic and biochemical analysis of the intracellular trafficking of the Alzheimer's β/A4 amyloid precursor protein. J. Neurosci. 14:1994;3122-3138.
40. Caputi A., Barindelli S., Pastorino L., Cimino M., Buxbaum J. D., Cattabeni F., Di Luca M. Increased secretion of the amino-terminal fragment of amyloid precursor protein in brains of rats with a constitutive up-regulation of protein kinase C. J. Neurochem. 68:1997;2523-2529.
41. Carter B. D., Kaltschmidt C., Kaltschmidt B., Offenhäuser N., Böhm-Matthaei R., Baeuerle P., Barde Y.-A. Selective activation of NF-κB by nerve growth factor through the neurotrophin receptor p75. Science. 272:1996;542-545.
42. Cassacia-Bonnefil P., Carter B., Dobrowsky R. T., Chao M. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature. 383:1996;716-719.
43. Chao M. The p75 neurotrophin receptor. J. Neurobiol. 25:1994;1373-1385.
44. Chao C. C., Hu S., Frey W. H., Ala T. A., Tourtellotte W. W., Peterson P. K. Transforming growth factor β in Alzheimer's disease. Clin. Diag. Lab. Immunol. 1:1994;109-110.
45. Chen M., Yankner B. A. An antibody to β-amyloid and the amyloid precursor protein inhibits cell-substratum adhesion in many mammalian cell types. Neurosci. Lett. 125:1991;223-226.
46. Chozick B. The nucleus basalis of Meynert in neurological dementing disease: a review. Int. J. Dev. Neurosci. 37:1987;31-48.
47. Citron M., Westaway D., Xia W. M., Carlson G., Diehl T., Levesque G., Johnson-Wood K., Lee M., Seubert P., Davis A., Kholodenko D., Motter R., Sherrington R., Perry B., Yao H., Strome R., Lieberburg I., Rommens J., Kim S., Schenk D., Fraser P., Hyslop P. S., Selkoe D. J. Mutant presenilins of Alzheimer's disease increase production of 42 residue amyloid β protein in both transfected cells and transgenic mice. Nature Med. 3:1997;67-72.
48. Clark M. J., Gagnon J., Williams A. F., Braclay A. N. MRC OX-2 antigen: lymphoid/neuronal membrane glycoprotein with a structure like a single immunoglobuline light chain. EMBO J. 4:1985;113-118.
49. Clarris H. J., Nurcombe V., Small D. H., Beyreuther K., Masters C. Secretion of nerve growth factor from septum stimulates neurite outgrowth and release of the amyloid protein precursor of Alzheimer's disease from hippocampal explants. J. Neurosci. Res. 38:1994;248-258.
50. Clary D. O., Weskamp G., Austin L. R., Reichardt L. F. TrkA cross-linking mimics neuronal responses to nerve growth factor. Mol. Biol. Cell. 5:1994;549-563.
51. Conner J. M., Muir D., Varon S., Hagg T., Manthorpe M. The localization of nerve growth factor-like immunoreactivity in the adult rat basal forebrain and hippocampal formation. J. Comp. Neurol. 319:1992;454-462.
52. Connor D. J., Langlais P. J., Thal L. Behavioral impairments after lesions of the nucleus basalis by ibotenic acid and quisqualic acid. Brain Res. 555:1991;84-90.
53. Cook D. B., Sung C. J., Golde T. E., Felsenstein K. M., Wojczyk B. S., Tanzi R. E., Trojanowski J. Q., Lee V. M. Y., Doms R. W. Expression and analysis of presenilin 1 in a human neuronal system: localization in cell bodies and dendrites. Proc. natl Acad. Sci. U.S.A. 93:1996;9223-9228.
54. 125I)NGF by cholinergic neurons and down-regulated trkA expression in the medial septum of aged rats. Neuroscience. 62:1994;625-629.
55. Corder E. H., Suanders A. M., Strittmatter W. J., Schmechel D. E., Gaskell P. C., Small G. W., Roses A. D., Haines J. L., Pericak-Vance M. A. Gene dose of apolipoprotein E type 4 allel and the risk of Alzheimer's disease. Science. 261:1993;921-923.
56. Coyle J. T., Price D. L., DeLong M. R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science. 219:1983;1184-1190.
57. Crutcher K. A., Scott S. A., Liang S., Everson W. V., Weingartner J. Detection of NGF-like activity in human brain tissue - increased levels in Alzheimer's disease. J. Neurosci. 13:1993;2540-2550.
58. Culvenor J. G., Maher F., Evin G., Malchiodialbedi F., Cappai R., Underwood J. R., Davis J. B., Karran E. H., Roberts G. W., Beyreuther K., Masters C. L. Alzheimer's disease-associated presenilin-1 in neuronal cells - evidence for localization to the endoplasmatic reticulum Golgi intermediate compartment. J. Neurosci. Res. 49:1997;719-731.
59. Cummings B. J., Cotman C. W. Image-analysis of beta-amyloid load in Alzheimer's disease and relation to dementia severity. Lancet. 346:1995;1524-1528.
60. Cummings B. J., Head E., Afagh A. J., Milgram N. W., Cotman C. W. Beta-amyloid accumulation correlates with cognitive dysfunction in the aged canine. Neurobiol. Learning Memory. 66:1996;11-23.
61. Cutler N. R., Sramek J. J. Muscarinic M1-receptor agonists. Potential in the treatment of Alzheimer's disease. CNS Drugs. 3:1995;467-481.
62. daPenha-Berzaghi A. T., Cooper J., Castrén E., Zafra F., Sofroniew M., Thoenen H., Lindholm D. Cholinergic regulation of brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) but not neurotrophin-3 (NT-3) mRNA levels in the developing rat hippocampus. J. Neurosci. 13:1993;3818-3826.
63. Davies C. A., Mann D. M. Is the "preamyloid" of diffuse plaques in Alzheimer's disease really nonfibrillar? Am. J. Pathol. 143:1993;1464-1467.
64. Davies P., Maloney A. J. R. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet. 2:1976;1403-1404.
65. Davis R. E., Doyle P. D., Carroll R. T., Emmerling M. R., Jaen J. Cholinergic therapies for Alzheimer's disease: pallative or disease altering? Arzneim.-Forsch./Drug Res. 45:1995;425-431.
66. Dawbarn D., Allen S. J., Semenenko F. M. Coexistence of choline acetyltransferase and nerve growth factor receptors in the rat basal forebrain. Neurosci. Lett. 94:1988;138-144.
67. Dawson V. L., Hunt M. E., Wamsley J. K. Alterations in cortical muscarinic receptors following cholinotoxin (AF64A) lesion of the rat nucleus basalis magnocellularis. Neurobiol. Aging. 13:1991;25-32.
68. Dechant G., Rodriguez-Tebar A., Barde Y. A. Neurotrophin receptors. Progr. Neurobiol. 42:1994;347-352.
69. Dekker A. J., Thal L. J. Effect of delayed treatment with nerve growth factor on acetylcholine transferase activity in the cortex of rats with lesions of nucleus basalis magnocellularis: dose requirements. Brain Res. 584:1992;55-63.
70. Dekker A. J., Langdon D. J., Gage F. H., Thal L. J. NGF increases acetylcholine release in rats with lesion of nucleus basalis. NeuroReport. 2:1991;577-580.
71. Dekker A. J., Gage F. H., Thal L. J. Delayed treatment with nerve growth factor improves aquisition of a spatial task in rats with lesion of nucleus basalis magnocellularis: evaluation of the involvement of different neurotransmitter systems. Neuroscience. 48:1992;111-119.
72. De Lacalle S., Cooper J. D., Svendsen C. N., Dunnett S. B., Sofroniew M. V. Reduced retrograde labeling with fluorescent tracer accompanies neuronal atrophy of basal forebrain cholinergic neurons in aged rats. Neuroscience. 75:1996;19-27.
73. De Sarno, P., Giacobini, E., McIlhany, M. and Clark, B. (1988) Nicotinic receptors in human CNS: a biopsy study. In: Proceedings 2nd Intl. Symposium on Senile Dementias, pp. 329-334, Ed. A. Agnoli. John Libbey Eurotext Ltd, Montrouge, France.
74. De Stropper B., Saftig P., Craessaerts K., Vanderstichele H., Guhde G., Annaert W., von Figura K., Van Leuven F. Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein. Nature. 391:1998;387-390.
75. Dickson D. W., Crystal H. A., Mattiace L. A., Masur D. M., Blau A. D., Davies P., Yen S. H., Aronson M. Identification of normal and pathological aging in prospectively studied nondemented elderly humans. Neurobiol. Aging. 13:1991;179-189.
76. DiStefano P. S., Friedman B., Radziejewski C., Alexander C., Boland P., Schick C. M., Lindsay R. M., Wiegand S. J. The neurotrophins BDNF, NT-3 and NGF display distinct patterns of retrograde axonal transport in peripheral and central neurons. Neuron. 8:1992;983-993.
77. Dobrowsky R. T., Werner M. H., Castellino A. M., Chao M. V., Hannun Y. A. Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science. 265:1994;1596-1599.
78. Dobrowsky R. T., Jenkins G. M., Hannun Y. A. Neurortrophins induce sphingomyelin hydrolysis - modulation by coexpression of p75(NTR) with Trk receptors. J. Biol. Chem. 270:1995;22135-22142.
79. Drewes G., Lichtenberg-Kraag B., Doering F., Mandelkow E. M., Biernat J., Goris J., Doree M., Mandelkow E. Mitogen-activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J. 6:1992;2131-2138.
80. Duff K., Eckman C., Zehr C., Yu X., Prada C. M., Perez-Tur J., Hutton M., Buee L., Harigaya Y., Yager D., Morgan D., Gordon M. N., Holcomb L., Refolo L., Zenk B., Hardy J., Younkin S. Increased amyloid beta 42(43) in brains of mice expressing mutant presenilin-1. Nature. 383:1996;710-713.
81. Dunnett S. B., Everitt B. J., Robbins T. W. The basal forebrain-cortical cholinergic system: interpreting the functional consequences of excitotoxic lesions. Trends Neurosci. 14:1991;494-501.
82. Dutar P., Bassant M.-H., Senut M.-C., Lamour Y. The septohippocampal pathway: structure and function of a central cholinergic pathway. Physiol. Rev. 75:1995;393-427.
83. Dyrks T., Weidemann A., Multhaup G., Salbaum J. M., Lemaire H. G., Kang J., Müller-Hill B., Masters C. L., Beyreuther K. Identification, transmembrane orientation and biogenesis of the amyloid A4 precursor of Alzheimer's disease. EMBO J. 7:1988;949-957.
84. Dyrks T., Mönning U., Beyreuther K., Turner J. Amyloid precursor protein secretion and beta A4 amyloid generation are not mutually exclusive. FEBS Lett. 349:1994;210-214.
85. Dyrks T., Dyrks E., Masters C., Beyreuther K. Amyloidogenicity of rodent and human βA4 sequences. FEBS Lett. 324:1993;231-236.
86. Edsal L. C., Pirianov G. G., Spiegel S. Involvement of sphingosine 1-phosphate in nerve growth factor-mediated neuronal survival and differentiation. J. Neurosci. 15:1997;6952-6960.
87. Elder G. A., Tezesidis N., Carter J., Shioi J., Bouras C., Li D., Johnston J. M., Efthimiopolous S., Friedrich V. L., Robakis N. K. Identification and neuron specific expression of the S182/presenilin 1 protein in human and rodent brain. J. Neurosci. Res. 45:1996;308-320.
88. Emre M., Geula C., Ransil B. J., Mesulam M. M. The acute neurotoxicity and effects upon cholinergic axons of intracerebrally injected β-amyloid in the rat brain. Neurobiol. Aging. 13:1992;553-559.
89. Ensinger H. A., Bechtel W.-D., Birke F. W., Mendla K. D., Mierau J., Speck G., Tröger W. WAL 2014 FU (Talsaclidine): A preferentially neuron activating muscarinic agonist for the treatment of Alzheimer's disease. Drug Dev. Res. 40:1997;144-157.
90. Ernfors P., Bengtson J., Kokaia Z., Persson H., Lindvall O. Increased levels of messenger RNAs for neurotrophic factors in the brain during kindling epileptogenesis. Neuron. 7:1991;165-176.
91. Esch F. S., Keim P. S., Beattie E. C., Blacher R. W., Culwell A. R., Oltersdorf T., McClure D., Ward P. J. Cleavage of amyloid peptide during constitutive processing of its percursor. Science. 248:1990;1122-1124.
92. Estus S., Golde T. E., Kunishita T., Blades D., Lowery D., Eisen M., Usiak M., Qu X., Tabira T., Greenberg B. D., Younkin S. G. Potentially amyloidogenic, carboxy-terminal derivatives of the amyloid protein precursor. Science. 255:1992;726-728.
93. Estus S., Tucker H. M., Vanrooyen C., Wright S., Brigham E. F., Wogulis M., Rydel R. E. Aggregated amyloid β protein induces cortical neuronal apoptosis and concomitant apoptotic pattern of gene induction. J. Neurosci. 17:1997;7736-7745.
94. Everitt B. J., Robbins T. W. Central cholinergic systems and cognition. A. Rev. Psychol. 48:1997;649-684.
95. Fahnestock M., Scott S. A., Jette N., Weingartner J. A., Crutcher K. A. Nerve growth factor messenger RNA and protein levels measured in the same tissue from normal and Alzheimer's disease parietal cortex. Mol. Brain Res. 42:1996;175-178.
96. Farber S. A., Nitsch R. M., Schulz J. G., Wurtman R. J. Regulated secretion of β-amyloid precursor protein in rat brain. J. Neurosci. 15:1995;7442-7451.
97. Fibiger H. C., Damsma G., Day J. C. Behavioral pharmacology and biochemistry of central cholinergic neurotransmission. Adv. Exp. Med. Biol. 295:1991;399-414.
98. Fine A., Hoyle C., MacLean C. J., Levatte T. L., Baker H. F., Ridley R. M. Learning impairments following injection of a selective cholinergic immunotoxin, ME20.4 IgG-saporin, into the basal nucleus of Meynert in monkeys. Neuroscience. 81:1997;331-343.
99. Forloni G., Chiesa R., Smiroldo S., Verga L., Salmona M., Tagliavini F., Angeretti N. Apoptosis mediated toxicity induced by chronic application of β-amyloid fragment 25-35. NeuroReport. 4:1993;523-526.
100. Forloni G., Delbo R., Angeretti N., Smiroldo S., Gabellini N., Vantini G. Nerve growth factor does not influence the expression of beta amyloid precursor protein messenger RNA in rat brain - in vivo and in vitro studies. Brain Res. 620:1993;292-296.
101. Fukuchi K., Ho L. B., Younkin S. G., Kunkel D. D., Ogburn C. E., Leboeuf R. C., Furlong C. E., Deeb S. S., Nochlin D., Wegiel J., Wisniewski H. M., Martin G. M. High levels of circulating β-amyloid peptide do not cause cerebral β-amyloidosis in transgenic mice. Am. J. Pathol. 149:1996;219-227.
102. Fukuyama R., Chandrasekaran K., Rapoport S. I. Nerve growth factor-induced neuronal differentiation is accompanied by differential induction and localization of the amyloid precursor protein (APP) in PC12-cells and variant PC12S-cells. Mol. Brain Res. 17:1993;17-22.
103. Fuller S. J., Storey E., Li Q.-X., Smith I., Beyreuther K., Masters C. Intracellular production of βA4 amyloid of Alzheimer's disease: modulation by phosphoramidon and lack of of coupling to secretion of the amyloid precursor protein. Biochemistry. 34:1995;8091-8098.
104. Gabuzda D., Busciglio J., Yankner B. A. Inhibition of β-amyloid production by activation of protein kinase C. J. Neurochem. 61:1993;2326-2329.
105. Gall C. M., Murray K., Isackson P. J. Kainic acid induced seizures stimulate increased expression of nerve growth factor mRNA in the rat hippocampus. Mol. Brain Res. 9:1991;113-123.
106. Games D., Adams D., Alessandrini R., Barbour R., Berthelette P., Blackwell C., Carr T., Clemens J., Donaldson T., Gillespie F., Guido T., Hagoplan S., Johnsonwood K., Khan K., Lee M., Leibowitz P., Lieberburg I., Little S., Masliah E., McConlogue L., Montoyazavala M., Mucke L., Paganini L., Penniman E., Power M., Schenk D., Seubert P., Snyder B., Soriano F., Tan H., Vitale J., Wadsworth S., Wolozin B., Zhao J. Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein. Nature. 373:1995;523-527.
107. Gegelashvili G., Schousboe A., Linnemann D. Expression of amyloid precursor protein (APP) in rat brain and cultured neural cells. Int. J. Dev. Neurosci. 12:1994;703-708.
108. Giacobini E. Cholinergic receptors in human brain: effects of aging and Alzheimer disease. J. Neurosci. Res. 27:1990;548-560.
109. Giacobini E. Therapy for Alzheimer's-disease - symptomatic or neuroprotective? J. Neural. Transm. 43:1994;211-217.
110. Giacobini E. Alzheimer's disease: from molecular biology to therapy. Adv. Exp. Med. Biol. 429:1997;235-245.
111. Gibbs R. B., Pfaff D. W. In situ hybridization detection of trkA mRNA in brain: distribution, colocalization with p75NGFR and up-regulation by nerve growth factor. J. Comp. Neurol. 341:1994;324-339.
112. Gillespie S. L., Golde T. E., Younkin S. G. Secretory processing of the Alzheimer's amyloid beta/A4 protein precursor is increased by protein phosphorylation. Biochem. Biophys. Res. Commun. 187:1992;1285-1290.
113. Ginty D. D., Bonni A., Greenberg M. E. Nerve growth factor activates a Ras-dependent protein kinase that stimulates c-fos transcription via phosphorylation of CREB. Cell. 77:1994;627-638.
114. Givens B., Sarter M. Modulation of cognitive processes by transsynaptic activation of the basal forebrain. Behav. Brain Res. 84:1997;1-22.
115. Gnahn H., Hefti F., Heumann R., Schwab M. E., Thoenen H. NGF-mediated increase of choline acetyltransferase (ChAT) in the neonatal forebrain: evidence for a physiolgical role of NGF in the brain? Dev. Brain Res. 9:1983;45-52.
116. Goedert M. Tau protein and the neurofibrillary pathology of Alzheimer's disease. Trends Neurosci. 16:1993;460-465.
117. Goedert M., Fine A., Hunt S. P., Ullrich A. Nerve growth factor mRNA in peripheral and central rat tisues and in the human central nervous system: lesion effects in the rat brain and levels in Alzheimer's disease. Mol. Brain Res. 1:1986;85-92.
118. Goedert M., Crowther R. A., Garner C. C. Molecular characterization of micotubule associated proteins Tau and MAP2. Trends Neurosci. 14:1991;193-199.
119. Golde T. E., Estus S., Younkin L. H., Selkoe D. J., Younkin S. G. Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. Science. 255:1992;728-730.
120. Gomeza J., Aragón C., Giménez C. High-affinity transport of choline and amino acid neurotransmitters in synaptosomes from brain regions after lesioning the nucleus basalis magnocellularis of young and aged rats. Neurochem. Res. 17:1992;345-350.
121. Graziadei P. P. C., Monti Graziadei G. A. Neurogenesis and neuron regeneration in the olfactory system of mammals.I. Morphological aspects of differentiation and structural organization of the olfactory sensory neurons. J. Neurocytol. 8:1979;1-18.
122. Greenamyre J. T., Maragos W. F. Neurotransmitter receptors in Alzheimer's disease. Cerebrovasc. Brain Met. Rev. 5:1993;61-94.
123. Grilli M., Ribola M., Alberici A., Valerio A., Memo M., Spano P. Identification and characterization of a kappa B/Rel binding site in the regulatory region of the amyloid precursor protein gene. J. Biol. Chem. 270:1995;26774-26777.
124. Guo G., Sopher B. L., Pham D. G., Furukawa K., Robinson N., Martin G. M., Mattson M. P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: involvement of calcium and oxyradicals. J. Neurosci. 17:1997;4212-4222.
125. Gwag B. J., Sessler F. M., Waterhouse B. D., Springer J. E. Regulation of nerve growth factor mRNA in the hippocampal formation: effects of N-Methyl-D-aspartate receptor activation. Exp. Neurol. 121:1993;160-171.
126. Haass C. Presenilins: genes for life and death. Neuron. 18:1997;687-690.
127. Haass C., Selkoe D. J. A technical KO of amyloid-β peptide. Nature. 391:1998;339-340.
128. Haass C., Koo E. H., Mellon A., Hung A. Y., Selkoe D. J. Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments. Nature. 357:1992;500-503.
129. Haass C., Hung A. Y., Schlossmacher M. G., Teplow D. B., Selkoe D. J. β-amyloid and a 3 kDa fragment are derived by distinct cellular mechanisms. J. Biol. Chem. 268:1993;3021-3024.
130. Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D., Teplow D. B., Selkoe D. J. Amyloid β-peptide is produced by cultured cells during normal metabolism. Nature. 359:1992;322-325.
131. Haass C., Lemere C. A., Capell A., Citron M., Seubert P., Schenk D., Lannfelt L., Selkoe D. J. The Swedish mutation causes early onset Alzheimer's disease by β-secretase cleavage within the secretory pathway. Nature Med. 1:1995;1291-1296.
132. Hantzopoulos P. A., Suri C., Glass D. J., Goldfarb M. P., Yancopoulos G. D. The low affinity NGF receptor, p75, can collaborate with each of the Trks to potentiate functional responses to the neurotrophins. Neuron. 13:1994;187-201.
133. Haring R., Gurwitz D., Barg J., Pinkas-Kramarsky R., Heldman E., Pittel Z., Wengier A., Meshulam H., Marciano D., Karton Y., Fisher A. Amyloid precursor protein secretion via muscarinic receptors-reduced desensitization using the M1-selective agonist AF102B. Biochem. Biophys. Res. Commun. 203:1994;652-658.
134. Haroutunian V., Greig N., Pei X.-F., Utsuki T., Gluck R., Acevedo L. D., Davis K. L., Wallace W. C. Pharmacological modulation of Alzheimer's disease β-amyloid precursor protein levels in the CSF of rats with forebrain cholinergic system lesions. Mol. Brain Res. 46:1997;161-168.
135. Hartmann T., Bieger S. C., Bruhl B., Tienari P. J., Ida N., Allsop D., Roberts G. W., Masters C. L., Dotti C. G., Unsicker K., Beyreuther K. Distinct sites of intracellular production for Alzheimer's disease Aβ-40/42 amyloid peptides. Nature Med. 3:1997;1016-1020.
136. He Y., Delaére P., Duyckaerts C., Wasowicz C., Piette F., Hauw J. J. Two distinct ubiquitin immunoreactive senile plaques in Alzheimer's disese: relationship with intellectual status in 29 cases. Acta Neuropathol. (Berl.). 86:1993;109-116.
137. Heckers S., Ohtake T., Wiley R. G., Lappi D. A., Geula C., Mesulam M. M. Complete and selective cholinergic denervation of rat neocortex and hippocampus but not amygdala by an immunotoxin against the p75 NGF receptor. J. Neurosci. 14:1994;1271-1289.
138. Hefti F. Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J. Neurosci. 6:1986;2155-2162.
139. Hefti F., Hartikka J., Eckenstein F., Gnahn H., Heumann R., Schwab M. E. Nerve growth factor (NGF) increases choline acetyltransferase but not survival or fiber growth of cultured cholinergic neurons. Neuroscience. 14:1985;55-68.
140. Hempstead B. L., Martin-Zanca D., Kaplan D. R., Parada L. F., Chao M. V. High-affinity NGF binding requires co-expression of the trk proto-oncogene and the low affinity NGF receptor. Nature. 350:1991;678-683.
141. Hesse L., Beher D., Masters C. L., Multhaup G. The βA4 amyloid precursor protein binding to copper. FEBS Lett. 349:1994;109-116.
142. Higgins L. S., Catalano R., Quon D., Cordell B. Transgenic mice expressing human βAPP751, but not mice expressing βAPP695, display early Alzheimer's disease-like histopathology. Ann. N.Y. Acad. Sci. 695:1993;224-227.
143. Higgins L. S., Holtzman D. M., Rabin J., Mobley W. C., Cordell B. Transgenic mouse brain histopathology resembles early Alzheimer's disease. Ann. Neurol. 35:1994;598-607.
144. Higgins L. S., Rodems J. M., Catalano R., Quon D., Cordell B. Early Alzheimer's disease-like histopathology increases in frequency with age in mice transgenic for βAPP 751. Proc. natl Acad. Sci. U.S.A. 92:1995;4402-4406.
145. Ho L. B., Fukuchi K., Younkin S. G. The alternativley spliced Kunitz protease inhibitor domain alters amyloid beta protein precursor processing and amyloid beta protein production in cultured cells. J. Biol. Chem. 271:1996;30929-30934.
146. Hörtnagel H., Hellweg R. Insights into the role of the cholinergic component of the septohippocampal pathway: what have we learned from experimental lesion studies? Brain Res. Bull. 43:1997;245-255.
147. Holley L. A., Wiley R. G., Lappi D. A., Sarter M. Cortical cholinergic deafferentation following the intracortical infusion of 192IgG-saporin: a quantitative histochemical study. Brain Res. 663:1994;277-286.
148. Holtzman D. M., Li Y., Parada L. F., Kinsman S., Chen C. K., Valletta J. S., Zhou J., Long J. B., Mobley W. C. p140trk mRNA marks NGF-responsive forebrain neurons: evidence that trk gene expression is induced by NGF. Neuron. 9:1992;465-478.
149. Hoshi M., Takashima A., Murayama M., Yasutake K., Yoshida N., Ishiguro K., Hoshino T., Imahori K. Nontoxic amyloid β peptide (1-42) supresses acetylcholine synthesis - possible role in cholinergic dysfunction in Alzheimer's disease. J. Biol. Chem. 272:1997;2038-2041.
150. Hsiao K. K., Borchelt D. R., Olson K., Johannsdottir R., Kitt C., Yunis W., Xu S., Eckman C., Younkin S., Price D. Age-realted CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor proteins. Neuron. 15:1995;1203-1218.
151. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
152. Hulme E. C., Birdsall N. J. M., Buckley N. J. Muscarinic receptor subtypes. A. Rev. Pharmac. Toxic. 30:1990;633-673.
153. Hung A. Y., Selkoe D. J. Selective ectodomain phosphorylation and regulated cleavage of β-amyloid precursor protein. EMBO J. 13:1994;534-542.
154. Hung A. Y., Koo E. H., Haas C., Selkoe D. J. Increased expression of β-amyloid precursor protein during neuronal differentiation is not accompanied by secretory cleavage. Proc. natl Acad. Sci. U.S.A. 89:1992;9439-9443.
155. Hung A. Y., Haass C., Nitsch R. M., Qui W. Q., Citron M., Wurtman R. J., Growdon J. H., Selkoe D. J. Activation of protein kinase C inhibits cellular production of the amyloid beta-protein. J. Biol. Chem. 268:1993;22959-22962.
156. Hyman B. T., Elvage T. E., Reiter J. Extracellular signal-regulated kinases-localization of protein and messenger RNA in the human hippocampal formation and Alzheimer's disease. Am. J. Pathol. 144:1994;565-572.
157. Ip N. Y., Stitt T. N., Tapley P., Klein R., Glass D. J., Fandl J., Greene L. A., Barbacid M., Yancopoulos G. D. Similarities and differences in the way neurotrophins interact with the Trk receptors in neuronal and non-neuronal cells. Neuron. 10:1993;137-149.
158. Irizarry M. C., McNamara M., Fedorchak K., Hsiao K., Hyman B. T. APPsw transgenic micedevelop age-related Aβ deposits and neuropil abnormalities,
159. Irizarry M. C., Soriano F. S., McNamara M., Page K. J., Schenk D., Games D., Hyman B. T. Aβ deposition is associated with neuropil changes, but not with overt neuronal loss in the human amyloid precursor protein V717F (PDAPP) transgenic mouse. J. Neurosci. 15:1997;7053-7059.
160. Iwatsubo T., Odaka A., Suzuki N., Mizusawa H., Nukina N., Ihara Y. Visualization of Aβ42(43) and Aβ40 in senile plaques with end-specific Aβ monoclonals: evidence that an initially deposited species is Aβ42(43). Neuron. 13:1994;45-53.
161. Iwatsubo T., Mann D. M., Odaka A., Suzuki N., Ihara Y. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome. Ann. Neurol. 37:1995;294-299.
162. Jarret J. T., Lansbury P. T. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell. 73:1993;1055-1058.
163. Jarret J. T., Berger E. P., Lansbury P. T. The carboxy terminus of the β amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. Biochemistry. 32:1993;4693-4697.
164. Joachim C. L., Selkoe D. J. The seminal role of β-amyloid in the pathogenesis of Alzheimer's disease. Alz. Dis. Assoc. Disord. 6:1992;7-34.
165. Johnson-Wood K., Lee M., Motter R., Hu K., Gordon G., Barbour R., Khan K., Gordon M., Tan H., Games D., Lieberburg I., Schenk D., Seubert P., McConlogue L. Amyloid precursor protein processing and Aβ(42) deposition in a transgenic mouse model of Alzheimer's disease. Proc. natl Acad. Sci. U.S.A. 94:1997;1550-1555.
166. Jope R. S. Cholinergic muscarinic receptor signaling by the phosphoinositide signal transduction system in Alzheimer's disease. Alzheimer's Disease Rev. 1:1996;2-14.
167. Jope R. S., Song L., Powers R. E. Cholinergic activation of phosphoinositide signaling is impaired in Alzheimer's disease brain. Neurobiol. Aging. 18:1997;111-120.
168. Joyce J. N., Gibbs R. B., Cotman C. W., Marshall J. F. Regulation of muscarinic receptors in hippocampus following cholinergic denervation and reinnervation by septal and striatal transplants. J. Neurosci. 9:1989;2776-2791.
169. Kammesheidt A., Boyce F. M., Spanoyannis A. F., Cummings B. J., Ortegon M., Cotman C. W., Vaught J. L., Neve R. L. Amyloid deposition and neuronal pathology in transgenic mice expressing the carboxyterminal fragment of the Alzheimer's amyloid precursor in the brain. Proc. natl Acad. Sci. U.S.A. 89:1992;10857-10861.
170. Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K., Müller Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell surface receptor. Nature. 325:1987;733-736.
171. Kaplan D. R., Hempstead B. L., Martin-Zanca D., Chao M. V., Parada L. F. The trk proto-oncogene product: a signal transducing receptor for NGF. Science. 252:1991;554-558.
172. Kar S., Seto D., Gaudreau P., Quirion R. β-amyloid-related peptides inhibit potassium-evoked acetylcholine release from rat hippocampal slices. J. Neurosci. 16:1996;1034-1040.
173. Kelly J. F., Furukawa K., Barger S. W., Rengen M. R., Mark R. J., Blanc E. M., Roth G. S., Mattson M. P. Amyloid β peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. natl Acad. Sci. U.S.A. 93:1996;6753-6758.
174. Kitaguchi N., Takahashi Y., Tokushima Y., Shiojiri S., Ito H. Novel precursor of Alzheimer's disease amyloid protein shows protease inhibitory activity. Nature. 331:1988;530-532.
175. Klunck W. E., McClure R. J., Pettegrew J. W. Possible roles of L-phosphoserine in the pathogenesis of Alzheimer's disease. Mol. Chem. Neuropath. 15:1991;51-73.
176. Kola I., Hertzog P. J. Animal models in the study of the biological function of genes on human chromosome 21 and their role in the pathophysiology of Down syndrome. Human Mol. Genetics. 6:1997;1713-1727.
177. König G., Mönning U., Czech C., Prior R., Banati R., Schreiter-Gasser U., Bauer J., Masters C. L., Beyreuther K. Identification and differential expression of a novel alternative splice isoform of β/A4 amyloid precursor protein (APP) mRNA in leucocytes and brain microglial cells. J. Biol. Chem. 267:1992;10804-10809.
178. Kordower J. H., Mufson E. J., Fox N., Martel L., Emerich D. F. Cellular delivery of NGF does not alter the expression of β-amyloid immunoreactivity in young and aged nonhuman primates. Exp. Neurol. 145:1997;586-591.
179. Korsching S., Auburger G., Heumann R., Scott J., Thoenen H. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J. 4:1985;1389-1393.
180. Korsching S., Auburger G., Heumann R., Scott J., Thoenen H. Cholinergic denervation of the rat hippocampus leads to a transient accumulation of nerve growth factor (NGF) without change in mRNA content. Neurosci. Lett. 66:1986;175-180.
181. Kovacs D. M., Fausett H. J., Page K. J., Kim T.-W., Moir R. D., Merriam D. E., Hollister R. D., Hallmark O. D., Mancini R., Felsenstein K. M., Hyman B. T., Tanzi R. E., Wasco W. Alzheimer-associated presenilins 1 and 2: neuronal expression in brain and localization to intracellular membranes in mammalian cells. Nature Med. 2:1996;224-229.
182. Kowall N. W., Beal M. F., Busciglio J., Duffy L. K., Yankner B. A. An in vivo model for the neurodegenerative effects of β-amyloid and protection by substance P. Proc. natl Acad. Sci. U.S.A. 88:1991;7247-7251.
183. Kromer L. F. Nerve growth factor treatment after brain injury prevents neuronal death. Science. 235:1987;214-216.
184. LaFerla F. M., Tinkle B. T., Bieberich C. J., Haudenschild C. C., Jay G. The Alzheimer's Aβ peptide induces neurodegeneration and apoptotic cell death in transgenic mice. Nature Genet. 9:1995;21-30.
185. Lauterborn J. C., Isackson P. J., Gall C. M. Nerve growth factor mRNA-containing cells are distributed within regions of cholinergic neurons in the rat basal forebrain. J. Comp. Neurol. 306:1991;439-446.
186. Lauterborn J. C., Tran T. M. D., Isackson P. J., Gall C. M. Nerve growth factor mRNA is expressed by GABAergic neurons in rat hippocampus. NeuroReport. 5:1993;273-276.
187. Leanza G., Nilsson O. G., Wiley R. G., Bjorklund A. Selective lesioning of basal forebrain cholinergic system by intraventricular 192IgG-saporin: behavioral, biochemical and stereological studies. Eur. J. Neurosci. 7:1995;329-343.
188. Leanza G., Nikkhah G., Nilsson O. G., Wiley R. G., Björklund A. Extensive reinnervation of the hippocampus by embryonic basal forebrain cholinergic neurons grafted into the septum of neonatal rats with selective cholinergic lesions. J. Comp. Neurol. 373:1996;355-372.
189. Lee M. K., Slunt H. H., Martin L. H., Thinakaran G., Kim G., Gandy S. E., Seeger M., Koo E., Price D. L., Sisodia S. S. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues. J. Neurosci. 16:1996;7513-7525.
190. Lee R. K., Wurtman R. J., Cox A. J., Nitsch R. M. Amyloid precursor protein processing is stimulated by metabotropic glutamate receptors. Proc. natl Acad. Sci. U.S.A. 92:1995;8083-8087.
191. Lehericy S., Hirsch E. C., Cervera-Pierot P., Hersh L. B., Bakchine S., Piette F., Duyckaerts C., Hauw J. J., Javoy-Agid F., Agid Y. Heterogeneity and selectivity of the degeneration of cholinergic neurons in the basal forebrain of patients with Alzheimer's disease. J. Comp. Neurol. 330:1993;15-31.
192. Lemke R., Härtig W., Roßner S., Bigl V., Schliebs R. Interleukin-6 is not expressed in activated microglia and in ractive astrocytes in response to lesion of rat basal basal forebrain cholinergic system as demonstrated by combined in situ hybridization and immunocytochemistry. J. Neurosci. Res. 51:1998;223-236.
193. Levey A. I. Muscarinic acetylcholine receptor expression in memory circuits: implications for Alzheimer's disease. Proc. natl Acad. Sci. U.S.A. 93:1996;13541-13546.
194. Lindefors N., Boatell M. L., Mahy N., Persson H. Widespread neuronal degeneration after ibotenic acid lesioning of cholinergic neurons in the nucleus basalis revealed by in situ hybridization. Neurosci. Lett. 135:1992;262-264.
195. Lindsay R. M., Wiegand S. J., Altar C. A., DiStefano P. S. Neurotrophic factors: from molecule to man. Trends Neurosci. 17:1994;182-190.
196. Löffler J., Huber G. β-amyloid precursor protein isoforms in various rat brain regions and during brain development. J. Neurochem. 59:1992;1316-1324.
197. Loo D., Copani A., Pike C. J., Whittemore E., Walancewicz A. J., Cotman C. W. Apoptosis is induced by β-amyloid in cultured central nervous system neurons. Proc. natl Acad. Sci. U.S.A. 90:1993;7951-7955.
198. Lucidi-Phillipi C. A., Clary D. O., Reichardt L. F., Gage F. H. TrkA activation is sufficient to rescue axotomized cholinergic neurons. Neuron. 16:1996;653-663.
199. MacGibbon G. A., Lawlor P. A., Sirimanne E. S., Walton M. R., Connor B., Young D., Williams C., Gluckman P., Faull R. L. M., Hughes P., Dragunow M. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus. Brain Res. 750:1997;223-234.
200. MacPhee I. J., Barker P. A. Brain-derived neurotrophic factor binding to the p75 neurotrophin receptor reduces TrkA signaling while increasing serine phosphorylation in the TrkA intracellular domain. J. Biol. Chem. 272:1997;23547-23551.
201. Maliartchouk S., Saragovi H. U. Optimal nerve growth factor signals mediated by synergy of TrkA and p75-specific ligands. J. Neurosci. 17:1997;6031-6037.
202. Mann D. M. A., Yates P. O., Marcyniuk B. Changes in nerve cells of the nucleus basalis of Meynert in Alzheimer's disease and their relationship to aging and to the accumulation of lipofuscin pigment. Mechan. Aging Dev. 25:1984;189-204.
203. Martin B. L., Schradefischer G., Busciglio J., Duke M., Paganetti P., Yankner B. A. Intracellular accumulation of β-amyloid in cells expressing the Swedish mutant amyloid precursor protein. J. Biol. Chem. 270:1995;26727-26730.
204. Martin L. J., Sisodia S. S., Koo E. H., Cork L. C., Dellovade T. L., Weidemann A., Beyreuther K., Masters C., Price D. L. β-amyloid precursor protein in aged nonhuman primates. Proc. natl Acad. Sci. U.S.A. 88:1991;1461-1465.
205. Mash D., Flynn D., Potter L. Loss of M2 muscarinic receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science. 228:1985;1115-1117.
206. Masliah E., Mallory M., Hansen L., Alford M., DeTeresa R., Terry R., Baudier J., Saitoh T. Localization of amyloid precursor protein in GAP-43 immunoreactive aberrant sprouting neurites in Alzheimer's disease. Brain Res. 574:1992;312-316.
207. Masliah E., Sisk A., Mallory M., Mucke L., Schenk D., Games D. Comparison of neurodegenerative pathology in transgenic mice overexpressing V717F β-amyloid precursor protein and Alzheimer's disease. J. Neurosci. 16:1996;5795-5811.
208. Mattson M. P., Guo Q. Cell and molecular neurobiology of presenilins: a role for the endoplasmatic reticulum in the pathogenesis of Alzheimer's disease? J. Neurosci. Res. 50:1997;505-513.
209. Mattson M. P., Cheng B., Culwell A. R., Esch F. S., Lieberburg I., Rydel R. E. Evidence for the excitoprotective and interneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron. 10:1993;243-254.
210. Mattson M. P., Guo Q., Furukawa K., Pedersen W. A. Presenilins, the endoplasmatic reticulum, and neuronal apoptosis in Alzheimer's disease. J. Neurochem. 70:1998;31-39.
211. McGaughy J., Kaiser T., Sarter M. Behavioral vigilance following infusions of 192IgG-saporin into the basal forebrain: selectivity of the behavioral impairment and relation to cortical AChE-positive fiber density. Behav. Neurosci. 110:1996;247-265.
212. Mesulam M. M., Mufson E. J., Wainer B. H., Levey A. I. Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience. 10:1983;1185-1201.
213. 3H]acetylcholine release from a cortical synaptosom. J. Neurosci. 5:1985;1202-1206.
214. Miller D. L., Papayannoopoulos I. A., Styles J., Bobin S. A., Lin Y. Y., Biemann K., Iqbal K. Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch. Biochem. Biophys. 301:1993;41-52.
215. Mills J., Charest D. L., Lam F., Beyreuther K., Ida N., Pelech S. L., Reiner P. B. Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway. J. Neurosci. 17:1997;9415-9422.
216. Milward E. A., Papadopoulos R., Fuller S. J., Moir R. D., Small D., Beyreuther K., Masters C. The amyloid protein precursor of Alzheimer's disease is a mediator of the effects of nerve growth factor on neurite outgrowth. Neuron. 9:1992;129-137.
217. Mobley W. C., Neve R. L., Prusiner S. B., McKinley M. P. Nerve growth factor increases mRNA levels for the prion protein and the β-amyloid precursor protein in the developing hamster brain. Proc. natl Acad. Sci. U.S.A. 85:1988;9811-9815.
218. Moran P. M., Higgins L. S., Cordell B., Moser P. C. Age-related learning deficits in transgenic mice expressing the 751 amino acid isoform of human β-amyloid precursor protein. Proc. natl Acad. Sci. U.S.A. 92:1995;5341-5345.
219. Mori F., Lai C.-C., Fusi F., Giacobini E. Cholinesterase inhibitors increase secretion of APPs in rat brain cortex. NeuroReport. 6:1995;633-636.
220. Mori H., Takio K., Ogawara M., Selkoe D. J. Mass spectrometry of purified amyloid β protein in Alzheimer's disease. J. Biol. Chem. 267:1992;17082-17086.
221. Moya K. L., Benowitz L. I., Schneider G. E., Allinquant B. The amyloid precursor protein is developmentally regulated and correlated with synaptogenesis. Dev. Biol. 161:1994;597-603.
222. Mucke L., Masliah E., Johnson W. B., Ruppe M. D., Alford M., Rockenstein E. M., Forsspechter S., Pietro-Poalo M., Mallory M., Abraham C. R. Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res. 666:1994;151-167.
223. Mucke L., Abraham C. R., Masliah E. Neurotrophic and neuroprotective effects of hAPP in transgenic mice. Ann. N.Y. Acad. Sci. 777:1996;82-88.
224. Mufson E. J., Bothwell M., Hersh L. B., Kordower J. H. Loss of nerve growth factor receptor-containing neurons in Alzheimer's disease: a quantitative analysis across subregions of the basal forebrain. Exp. Neurol. 105:1989;221-232.
225. Mufson E. J., Conner J. M., Kordower J. H. Nerve growth factor in Alzheimer's disease: defective retrograde transport to nucleus basalis. NeuroReport. 6:1995;1063-1066.
226. Mufson E. J., Li J. M., Sobreviela T., Kordower J. H. Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease. NeuroReport. 8:1996;25-29.
227. Mufson E. J., Lavine N., Jaffar S., Kordower J. H., Quirion R., Saragovi H. U. Reduction of p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease. Exp. Neurol. 146:1997;91-103.
228. Multhaup G., Beher D., Hesse L., Schlicksupp A., Pollwein P., Masters C. L., Beyreuther K. Identification of divalent ions as modulating factors for the function of the βA4 amyloid protein precursor. Neurobiol. Aging. 15:1994;S142.
229. Multhaup G., Schlicksupp A., Hesse L., Beher D., Ruppert T., Masters C. L., Beyreuther K. The amyloid precursor protein of Alzheimer's disease in the reduction of copper (II) to copper (I). Science. 271:1996;1406-1409.
230. Muroya K., Hattori S., Nakamura S. Nerve growth factor induces rapid accumulation of the GTP-bound form of p21ras in rat pheochromocytoma PC12 cells. Oncogene. 7:1992;277-281.
231. Nalbantoglu J., Tiradosantiago G., Lahsaini A., Poirier J., Goncalves O., Verge A., Momoli F., Welner S. A., Massicotte G., Julien J. P., Shapiro M. L. Impaired learning and LTP in mice expressing the carboxy-terminus of the Alzheimer amyloid precursor protein. Nature. 387:1997;500-505.
232. Narindrasorasak S., Lowery D. E., Altman R. A., Gonzales-DeWhitt P. A., Greenberg B. D., Kisilevsky R. Characterization of high-affinity binding between laminin and Alzheimer's disease amyloid precursor protein. Lab. Invest. 67:1992;643-652.
233. Neve R. L., Finch E. A., Dawes L. R. Expression of the Alzheimer amyloid precursor gene transcripts in the human brain. Neuron. 1:1988;669-677.
234. Neve R. L., Kammerscheidt D. T., Hohman C. F. Brain transplants of cells expressing the carboxy-terminal fragment of the Alzheimer amyloid precursor cause specific neuropathology in vivo. Proc. natl Acad. Sci. U.S.A. 89:1992;3448-3452.
235. Neve R. L., Valletta J. S., Li Y., Ventosa-Michelman M., Holtzman D. M., Mobley W. C. A comprehensive study of the spatiotemporal pattern of β-amyloid precursor protein mRNA and protein in the rat brain: lack of modulation by exogenously applied nerve growth factor. Mol. Brain Res. 39:1996;185-197.
236. Ng N. F. L., Shooter E. M. Activation of p21ras by nerve growth factor in embryonic sensory neurons and PC12 cells. J. Biol. Chem. 268:1993;25329-25333.
237. Nitsch R. M., Growdon J. H. Role of neurotransmission in the regulation of amyloid beta-protein precursor processing. Biochem. Pharmacol. 47:1994;1275-1284.
238. Nitsch R. M., Slack B. E., Wurtman R. J., Growdon J. H. Release of Alzheimer's amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science. 258:1992;304-307.
239. Nitsch R. M., Blusztajn J. K., Pittas A. G., Slack B. E., Growdon J. H., Wurtman R. J. Evidence for a membrane defect in Alzheimer's disease brain. Proc. natl Acad. Sci. U.S.A. 89:1992;1671-1675.
240. 2E receptors stimulate amyloid precursor protein ectodomain secretion. J. Biol. Chem. 271:1996;4188-4194.
241. Nordberg A. Neuroreceptor changes in Alzheimer's disease. Cerebrovasc. Brain Met. Rev. 4:1992;303-328.
242. Nordberg A. In vivo detection of neurotransmitter changes in Alzheimer's disease. Ann. NY Acad. Sci. 695:1993;27-33.
243. 3H]acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci. Lett. 72:1986;115-119.
244. 11C-nicotine in brain of Alzheimer patients visualized by positron emission tomography. J. Neural Transm. 2:1990;215-224.
245. Ohta M., Kitamoto T., Iwaki T., Ohgami T., Fukui M., Tateishi J. Immunohistochemical distribution of amyloid precursor protein during normal rat development. Dev. Brain Res. 75:1993;151-161.
246. Ohtake T., Heckers S., Wiley R. G., Lappi D. A., Mesulam M.-M., Geula C. Retrograde degeneration and colchicine protection of basal forebrain cholinergic neurons following hippocampal injection of an immunotoxin against the p75 nerve growth factor receptor. Neuroscience. 78:1997;123-133.
247. Ohyagi Y., Tabira T. Effect of growth factors and cytokines on expression of amyloid beta protein precursor messenger RNAs in cultured neural cells. Mol. Brain Res. 18:1993;127-132.
248. Ohyagi Y., Takahashi K., Kamegai M., Tabira T. Development and differential expression of beta amyloid protein precursor mRNAs in mouse brain. Biochem. Biophys. Res. Commun. 167:1990;54-60.
249. Oltersdorf T., Fritz L. C., Schenk D. B., Lieberburg I., Johnson-Wood K. L., Beattie E. C., Ward P. J., Blacher R. W., Dovey H. F., Sinha S. The secreted form of the Alzheimer's amyloid precursor protein with the Kunitz domain is protease nexin-II. Nature. 341:1989;144-147.
250. Oster-Granite M. L., McPhie D. L., Greenan J., Neve R. L. Age-dependent neuronal and synaptic degeneration in mice transgenic for C-terminus of the amyloid precursor protein. J. Neurosci. 16:1996;6732-6741.
251. Paradis E., Douillard H., Koutroumanis M., Goodyer C., LeBlanc A. Amyloid β peptide of Alzheimer's disease downregulates Bcl-2 and upregulates Bax expression in human neurons. J. Neurosci. 16:1996;7533-7539.
252. Pedersen W. A., Kloczewiak M. A., Blusztajn J. K. Amyloid β protein reduces acetylcholine synthesis in a cell line derived from cholinergic neurons of the basal forebrain. Proc. natl Acad. Sci. U.S.A. 93:1996;8068-8071.
253. Pedersen W. A., Guo Q., Hartman B. K., Mattson M. P. Nerve growth factor independent reduction in choline acetyltransferase activity in PC12 cells expressing mutant presenilin-1. J. Biol. Chem. 272:1997;22397-22400.
254. Peraldi P., Scimeca J. C., Filloux C., Van Obberghen E. Regulation of extracellular signal-regulated protein kinase-1 (ERK-1; pp44/mitogen-activated protein kinase) by epidermal growth factor and nerve growth factor in PC12 cells: implication of ERK1 inhibitory activities. Endocrinology. 132:1993;2578-2585.
255. Peralta F. G., Ashkenazi A., Winslow J. W., Smith D. H., Ramachandran J., Capon D. J. Distinct primary structures, ligand binding properties and tissue-specific expression of four human muscarinic acetylcholine receptors. EMBO J. 6:1987;3923-3929.
256. Peralta F. G., Ashkenazi A., Winslow J. W., Ramachandran J., Capon D. J. Differential regulation of PI hydrolysis and adenyl cyclase by muscarinic receptor subtypes. Nature. 334:1988;434-437.
257. Peraus G. C., Masters C. L., Beyreuther K. Late compartments of amyloid precursor protein transport in SY5Y cells are involved in β-amyloid secretion. J. Neurosci. 17:1997;7714-7724.
258. Perry E. K. The cholinergic hypothesis - ten years on. Br. Med. Bull. 42:1986;63-69.
259. Perry E. K., Gibson P. H., Blessed G., Perry R. H., Tomlinson B. E. Neurotransmitter enzyme abnormalities in senile dementia. J. Neurol. Sci. 34:1977;247-265.
260. Perry E. K., Tomlinson B. E., Blessed G., Bergmann K., Gibson G. H., Perry R. H. Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. Br. Med. J. 2:1978;1457-1459.
261. Pike C. J., Walancewicz A. J., Glabe C. G., Cotman W. In vitro aging of β-amyloid protein causes protein aggregation and neurotoxicity. Brain Res. 563:1991;311-314.
262. Podlisny M. B., Stephenson D. T., Frosch M. P., Lieberburg I., Clemens J. A., Selkoe D. J. Synthetic β-amyloid peptide fails to produce specific neurotoxicity in monkey cerebral cortex. Neurobiol. Aging. 13:1992;561-568.
263. Ponte P., Gonzales DeWhitt P., Schilling J., Miller J., Hsu D., Greenberg B., Davis K., Wallace W., Lieberburg I., Fuller F., Cordell B. A new A4 amyloid mRNA contains a domain homologous to serine protease inhibitors. Nature. 331:1988;525-532.
264. Qui W., Ferreira A., Miller C., Koo E. H., Selkoe D. J. Cell-surface β-amyloid precursor protein stimulates neurite outgrowth of hippocampal neurons in an isoform-dependent manner. J. Neurosci. 15:1995;2157-2167.
265. Reinikainen K. J., Riekkinen P. F., Halonen T., Laakso M. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease. Life Sci. 41:1987;453-461.
266. Richards M. H. Pharmacology and second messenger interactions of cloned muscarinic receptors. Biochem.Pharmacol. 42:1991;1645-1653.
267. Rinne J. O., Lönnberg P., Marjamäki P., Rinne U. K. Brain muscarinic receptor subtypes are differently affected in Alzheimer's disease and Parkinson's disease. Brain Res. 483:1989;402-406.
268. Rius R. A., Edsal L. C., Spiegel S. Activation of sphingosine kinase in pheochromocytoma PC12 neuronal cells in response to trophic factors. FEBS Lett. 417:1997;173-176.
269. Robinson J. K., Wenk G. L., Wiley R. G., Lappi D. A., Crawley J. N. 192IgG-saporin immunotoxin and ibotenic acid lesions of nucleus basalis and medial septum produce comparable deficits on delayed nonmatching to position in rats. Psychobiology. 24:1996;179-186.
270. Rodriguez-Tebar A., Dechant G., Gotz R., Barde Y. A. Binding of neurotrophin-3 to its neuronal receptors and interactions with nerve growth factor and brain-derived neurotrophic factor. EMBO J. 11:1992;917-922.
271. Roßner S., Perez-Polo J. R., Wiley R. G., Schliebs R., Bigl V. Differential expression of immediate early genes in distinct layers of rat cerebral cortex after selective immunolesion of the forebrain cholinergic system. J. Neurosci. Res. 38:1994;282-293.
272. Roßner S., Härtig W., Schliebs R., Brückner G., Brauer K., Perez-Polo J. R., Wiley R. G., Bigl V. 192IgG-saporin immunotoxin-induced loss of cholinergic cells differentially activates microglia in rat basal forebrain nuclei. J. Neurosci. Res. 41:1995;335-346.
273. Roßner S., Schliebs R., Perez-Polo J. R., Wiley R. G., Bigl V. Differential changes in cholinergic markers from selected brain regions after specific immunolesion of rat cholinergic basal forebrain system. J. Neurosci. Res. 40:1995;31-43.
274. Roßner S., Schliebs R., Härtig W., Bigl V. 192IgG-saporin-induced selective lesion of cholinergic basal forebrain system: neurochemical effects on cholinergic neurotransmission in rat cerebral cortex and hippocampus. Brain Res. Bull. 38:1995;371-381.
275. Roßner S., Schliebs R., Perez-Polo J. R., Wiley R. G., Bigl V. Differential changes in cholinergic markers from selected brain regions after specific immunolesion of the rat cholinergic basal forebrain system. J. Neurosci. Res. 40:1995;31-43.
276. Roßner S., Yu J., Pizzo D., Werrbach-Perez K., Schliebs R., Bigl V., Perez-Polo J. R. Effects of intraventricular transplantation of NGF-secreting cells on cholinergic basal forebrain neurons after partial immunolesion. J. Neurosci. Res. 45:1996;40-56.
277. Roßner S., Schliebs R., Härtig W., Perez-Polo J. R., Bigl V. Selective induction of c-Jun and NGF in reactive astrocytes after cholinergic degenerations in rat basal forebrain. NeuroReport. 8:1997;2199-2202.
278. Roßner S., Ueberham U., Yu J., Kirazov L., Schliebs R., Perez-Polo J. R., Bigl V. In vivo regulation of amyloid precursor protein secretion in rat neocortex by cholinergic activity. Eur. J. Neurosci. 9:1997;2125-2134.
279. Roßner S., Wörtwein G., Gu Z., Yu J., Schliebs R., Bigl V., Perez-Polo J. R. Cholinergic control of nerve growth factor in adult rats - evidence from cortical cholinergic deafferentation and chronic drug treatment. J. Neurochem. 69:1997;947-953.
280. Roßner, S., Ueberham, U., Schliebs, R., Perez-Polo, J. R. and Bigl, V. (1998) p75 and TrkA receptor signaling independently regulate APP mRNA expression, isoform composition and protein secretion in PC-12 cells. J. Neurochem. 70, in press.
281. Roth M., Tomlinson B. E., Blessed G. Correlation between scores for dementia and counts of senile plaques in cerebral grey matter of elderly subjects. Nature. 209:1966;109-110.
282. Rudelli R. D., Ambler M. W., Wisniewski H. M. Morphology and distribution of Alzheimer neuritic (senile) amyloid plaques in striatum and diencephalon. Acta Neuropathol. (Berl.). 64:1984;273-281.
283. Rush D. K., Aschmies S., Merriman M. C. Intracerebral β-amyloid (25-25) produces tissue damage. Is it neurotoxic? Neurobiol. Aging. 13:1992;591-594.
284. Rylett R. J., Goddard S., Schmidt B. M., Williams L. R. Acetylcholine synthesis and release following continuous intracerebral administration of NGF in adult and aged Fischer-344 rats. J. Neurosci. 13:1993;3956-3963.
285. Sahasrabudhe S. R., Spruyt M. A., Muenkel H. A., Blume A. J., Vitek M. P., Jacobsen J. S. Release of amino-terminal of amyloid precursor protein reporter and mutated derivatives in cultured cells. J. Biol. Chem. 267:1992;25601-25608.
286. Saitoh T., Sunsdmo M., Roch J. M., Kimura N., Cole G., Schubert D., Oltersdorf T., Schenk D. B. Secreted form of amyloid β protein precursor is involved in the growth regulation of fibroblasts. Cell. 58:1989;615-622.
287. Salehi A., Verhaagen J., Dijkhuizen P. A., Swaab D. F. Co-localization of high-affinity neurotrophin receptors in nucleus basalis of Meynert neurons and their differential reduction in Alzheimer's disease. Neuroscience. 75:1996;373-387.
288. Sandbrink R., Masters C. L., Beyreuther K. βA4-amyloid protein precursor mRNA isoforms without exon 15 are ubiquitously expressed in rat tissues including rat brain, but not in neurons. J. Biol. Chem. 269:1994;1510-1517.
289. Saper C. B., German D. C., White C. L. Neuronal pathology in the nucleus basalis and associated cell groups in senile dementia of the Alzheimer's type: possible role in cell loss. Neurology. 35:1985;1089-1095.
290. Sarter M., Bruno J. P. Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Res. Rev. 23:1997;28-46.
291. de Sauvage F., Octave J. N. A novel mRNA of the A4 amyloid precursor gene coding for a possibly secreted protein. Science. 245:1989;651-653.
292. Sato M., Kawarabayashi T., Shoji M., Kobayashi T., Tada N., Matsubara E., Hirai S. Neurodegeneration and gliosis in transgenic mice overexpressing a carboxy-terminal fragment of Alzheimer amyloid beta protein precursor. Dem. Geriatr. Cogn. Disorders. 8:1997;296-307.
293. Satou T., Cummings T. J., Cotman C. W. Immunorecativity for bcl-2 protein within neurons in the Alzheimer's disease brain increases with disease severity. Brain Res. 697:1995;35-43.
294. Schliebs, R. and Bigl, V. (1996) Animal models to produce cortical cholinergic dysfunction. In: Methods in Neurosciences: Paradigms of Neural Injury, pp. 275-289. Ed. J. R. Perez-Polo. Academic Press, San Diego, CA.
295. Schradefischer G., Staufenbiel M., Paganetti P. A. Insertion of lysosomal targeting sequences to the amyloid precursor protein reduces secretion of beta A4. J. Neurochem. 68:1997;1571-1580.
296. Schröder H. Immunohistochemistry of cholinergic receptors. Anat. Embryol. 186:1992;407-429.
297. Schröder H., Giacobini E., Struble R. G., Zilles K., Maelicke A. Nicotinic cholinoceptive neurons of the frontal cortex are reduced in Alzheimer's disease. Neurobiol. Aging. 12:1991;259-262.
298. Schubert D., Schroeder R., LaCorbiere M., Saitoh T., Cole G. Amyloid protein is possibly a heparan sulfate proteoglycan core protein. Science. 241:1988;223-226.
299. Schubert D., Jin L. W., Saitoh T., Cole G. The regulation of amyloid beta precursor secretion and its modulatory role in cell adhesion. Neuron. 3:1989;689-694.
300. Schubert W., Prior R., Weidemann A., Dircksen H., Multhaupt G., Masters C. L., Beyreuther K. Localization of Alzheimer A4 amyloid precursor protein at central and peripheral synaptic sites. Brain Res. 563:1991;184-194.
301. Seeger G., Härtig W., Roßner S., Schliebs R., Brückner G., Bigl V., Brauer K. Electron microscopic evidence for microglial phagocytic activity and cholinergic cell death after administration of the immunotoxin 192IgG-saporin in rat. J. Neurosci. Res. 48:1997;465-476.
302. Seiler M., Schwab M. E. Specific retrograde transport of nerve growth factor (NGF) from neocortex to nucleus basalis in the rat. Brain Res. 300:1984;33-39.
303. Selkoe D. J. Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53:1994;429-437.
304. Selkoe D. J. Amyloid beta protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271:1996;18295-18298.
305. Seubert P., Vigo-Pelfrey C., Esch F., Leal M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J., Swindlehurst C., Mc Cormack R., Wolfert R., Selkoe D., Lieberburg I., Schenk D. Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature. 359:1992;325-327.
306. Seubert P., Oltersdorf T., Lee M. G., Barbour R., Blomquist C., Davis D. L., Bryant K., Fritz L. C., Galasko D., Thal L. J., Lieberburg I., Schenk D. B. Secretion of amyloid precursor protein cleaved at the amino terminus of the amyloid peptide. Nature. 361:1993;260-263.
307. Shin R.-W., Ogino K., Kondo A., Saido T. C., Trojanowski J. Q., Kitamoto T., Tateishi J. Amyloid β-protein (Aβ) 1-40 but not Aβ1-42 contributes to the experimental formation of Alzheimer's disease amyloid fibrils in rat brain. J. Neurosci. 17:1997;8183-8187.
308. Shivers B. D., Hilbich C., Multhaup G., Salbaum M., Beyreuther K., Seeburg P. H. Alzheimeŕs disease amyloidogenic glycoprotein: expression pattern in rat brain suggests a role in cell contact. EMBO J. 7:1988;1365-1370.
309. Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Schaffer L. M., Cai X.-D., McKay D. M., Tintner R., Frangione B., Younkin S. G. Production of the Alzheimer's amyloid β protein by normal proteolytic processing. Science. 258:1992;126-129.
310. Simons M., Destrooper B., Multhaup G., Tienari P. J., Dotti C. G., Beyreuther K. Amyloidogenic processing of the human amyloid precursor protein in primary cultures of rat hippocampal neurons. J. Neurosci. 16:1996;899-908.
311. Sisodia S. S. Beta-amyloid precursor protein cleavage by a membrane bound protease. Proc. natl Acad. Sci. U.S.A. 89:1992;6075-6079.
312. Sisodia S. S., Koo E. H., Beyreuther K., Unterbeck A., Price D. L. Evidence that β-amyloid protein in Alzheimer's disease is not derived by normal processing. Science. 248:1990;492-495.
313. Slack B. E., Nitsch R. M., Livneh E., Kunz G. M., Eldar H., Wurtman R. J. Regulation by phorbol esters of amyloid precursor protein release from Swiss 3T3 fibroblasts overexpressing protein kinase C. J. Biol. Chem. 268:1993;21097-21101.
314. Slack B. E., Breu J., Petryniak M. A., Srivastava K. S., Wurtman R. J. Tyrosine phosphorylation-dependent stimulation of amyloid precursor protein secretion by the m3 muscarinic acetylcholine receptor. J. Biol. Chem. 270:1995;8337-8344.
315. Slunt H. H., Thinakaran G., Vonkoch C., Lo A. C. Y., Tanzi R. E., Sisodia S. S. Expression of an ubiquitous, cross-homolog of the mouse β-amyloid precursor protein (APP). J. Biol. Chem. 269:1994;2637-2644.
316. Smith C. J., Perry E. K., Perry R. H., Candy J. M., Johnson M., Bonham J. R., Dick D. J., Fairbairn A., Blessed G., Birdsall N. J. M. Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders. J. Neurochem. 50:1988;847-856.
317. Smith C. J., Wion D., Brachet P. Nerve growth factor-induced neuronal differentiation is accompanied by differential splicing of beta-amyloid precursor messenger RNAs in the PC12 cell line. Mol. Brain Res. 10:1991;351-354.
318. Smith C. J., Johnson E. M., Osborne P., Freeman R. S., Neveu I., Brachet P. NGF deprivation and neuronal degeneration trigger altered beta-amyloid precursor protein gene-expression in the rat superior cervical ganglia in vivo and in vitro. Mol. Brain Res. 17:1993;328-334.
319. Snow A. D., Sekiguchi R., Nochlin D., Fraser P., kimata K., Mizutani A., Arai M., Scherier W. A., Morgan D. G. An important role of heparan sulfate proteoglycan (Perlacan) in a model system for the deposition and persistence of fibrillar Aβ-amyloid in rat brain. Neuron. 12:1994;219-234.
320. Soltoff S. P., Rabin S. L., Cantley L. C., Kaplan D. R. Nerve growth factor promotes the activation of phosphatidylinositol 3-kinase and its association with the trk tyrosine kinase. J. Biol. Chem. 267:1992;17472-17477.
321. Sprecher C. A., Grant F. J., Grimm G., Ohara P. J., Norris F., Norris K., Foster D. C. Molecular cloning of the cDNA for a human amyloid precursor protein homolog - evidence for a multigene family. Biochemistry. 32:1993;4481-4486.
322. Springer J. E., Koh S., Tayrien M. W., Loy R. Basal forebrain magnocellular neurons stain for nerve growth factor receptor: correlation with cholinergic cell bodies and effects of axotomy. Exp. Neurol. 106:1987;209-221.
323. Stein-Behrens B., Adams K., Yeh M., Sapolski R. Failure of beta amyloid protein fragment 25-35 to cause hippocampal damage in the rat. Neurobiol. Aging. 13:1992;577-579.
324. Stephens D. J., Austen B. M. Metabolites of the beta amyloid precursor protein generated by β-secretase localize to the trans-Golgi network and late endosome in 293 cells. J. Neurosci. Res. 46:1996;211-225.
325. Strada O., Hirsch E. C., Javoy-Agid F., Lehericy S., Ruberg M., Hauw J. J., Agid Y. Does loss of nerve growth factor receptors precede loss of cholinergic neurons in Alzheimer's disease? An autoradiographic study in the human striatum and basal forebrain. J. Neurosci. 12:1992;4766-4774.
326. Su J., Anderson A., Cummings B., Cotman C. W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. NeuroReport. 5:1994;2529-2533.
327. Suzuki N., Cheung T. T., Cai X.-D., Odaka A., Otvos L., Eckman C., Golde T. E., Younkin S. G. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717). Science. 264:1994;1336-1340.
328. Svensson A.-L., Alafuzof I., Nordberg A. Characterization of muscarinic receptor subtypes in Alzheimer and control brain cortices by selective muscarinic antagonists. Brain Res. 596:1992;142-148.
329. trkA does not abolish nerve growth factor-mediated rescue of serum-free PC12 cells. J. Neurochem. 66:1996;1826-1835.
330. Tagliavani F., Giaccone G., Prelli F., Verga L., Porro M., Trojanowski J. Q., Farlow M. R., Frangione B., Ghetti B., Bugiani O. A68 is a component of paired helical filaments of Gerstmann-Straeussler-Scheinker disease, Indiana kindred. Brain Res. 616:1993;325-328.
331. Taniuchi M., Johnson E. M. Characterization of the binding properties and retrograde axonal transport of a monoclonal antibody directed against the rat nerve growth factor receptor. J. Cell Biol. 101:1985;1100-1106.
332. Tanzi R. E., Gusella J. F., Watkins P. C., Bruns G. A. P., St George Hyslop P. H., Vankeuren M. L., Patterson D., Pagan S., Kurnit D. M., Neve R. L. The amyloid beta protein gene: cDNA cloning, mRNA distribution, and genetic linkage near the Alzheimer locus. Science. 235:1987;880-884.
333. Tanzi R. E., McClatchey A. I., Lampert E. D., Villa-Komaroff L., Gusella J. F., Neve R. L. Protease inhibitor domain encoded by an amyloid protein precursor mRNA associated with Alzheimer's disease. Nature. 331:1988;528-530.
334. Thinakaran G., Teplow D. B., Siman R., Greenberg B., Sisodia S. S. Metabolism of the Swedish amyloid precursor protein variant in neuro2A cells - evidence that cleavage at the β-secretase site occurs in the Golgi apparatus. J. Biol. Chem. 271:1996;9390-9397.
335. Thoenen H. Neurotrophins and neuronal plasticity. Science. 270:1995;593-598.
336. Torres E. M., Perry T. A., Blokland A., Wilkinson L. S., Wiley R. G., Lappi D. A., Dunnett S. B. Behavioural, histochemical and biochemical consequences of selective immunolesions in discrete regions of the basal forebrain cholinergic system. Neuroscience. 63:1994;95-122.
337. Van Nostrand W. E., Wagner S. L., Suzuki M., Choi B. H., Farrow J. S., Geddes J. W., Cotman C. W., Cunningham D. D. Protease nexin-II, a potent antichymotrypsin, shows identity to amyloid beta-protein precursor. Nature. 341:1989;546-549.
338. Van Nostrand W. E., Wagner S. L., Shankle W. R., Farrows J. S., Dick M., Rozemuller J. M., Kuiper M. A., Wolters E. C., Zimmerman J., Cotman C. W., Cunningham D. D. Decreased levels of soluble β-amyloid protein precursor in cerebrospinal fluid of live Alzheimer's patients. Proc. natl Acad. Sci. U.S.A. 89:1992;2551-2555.
339. Van Nostrand W. E., Schmaier A. H., Neiditch B. R., Siegel R. S., Raschke W. C., Sisodia S. S., Wagner S. L. Expression, purification and characterization of the Kunitz-type proteinase inhibitor domain of the amyloid β-protein precursor-like protein-2. Biochim. Biophys. Acta. 1209:1994;165-170.
340. LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron. 12:1994;733-745.
341. Vetter M. L., Martin-Zanca D., Parada L. F., Bishop J. M., Kaplan D. R. Nerve growth factor rapidly stimulates tyrosine phosphorylation of phospholipase C-gamma 1 by a kinase activity associated with the product of the trk protooncogene. Proc. natl Acad. Sci. U.S.A. 88:1991;5650-5654.
342. Waite J. J., Cole G. M., Frautschy S. A., Conner D. J., Thal L. J. Solvent effects of beta protein toxicity in vivo. Neurobiol. Aging. 13:1992;595-600.
343. Waite J. J., Wardlow M. L., Chen A. D., Lappi D. A., Wiley R. G. Time course of cholinergic and monoaminergic changes in rat brain after immunolesioning with 192IgG-saporin. Neurosci. Lett. 169:1994;154-158.
344. Waite J. J., Chen A. D., Wardlow M. L., Wiley R. G., Lappi D. A., Thal L. J. 192 immunoglobulin G-saporin produces graded behavioral and biochemical changes accompanying the loss of cholinergic neurons of the basal forebrain and cerebellar Purkinje cells. Neuroscience. 65:1995;463-476.
345. van der Wal E. A., Gomez-Pinilla F., Cotman C. W. Transforming growth factor β1 is in plaques of Alzheimer and Down pathologies. NeuroReport. 4:1993;69-72.
346. Wallace W. C., Bragin V., Robakis N. K., Sambamurti K., Vander-Putten D., Merril C. R., Davis K. L., Santucci A. C., Haroutunian V. Increased biosynthesis of Alzheimer amyloid precursor protein in the cerebral cortex of rats with lesions of the nucleus basalis Meynert. Mol. Brain Res. 10:1991;173-178.
347. Wallace W. C., Ahlers S. T., Gotlib J., Sugar J., Gluck R., Shea P. A., Davis K. L., Haroutunian V. Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. Proc. natl Acad. Sci. U.S.A. 90:1993;8712-8716.
348. Wallace W. C., Lieberburg I., Schenk D., Vigo-Pelfrey C., Davis K. L., Haroutunian V. Chronic elevation of secreted amyloid precursor protein in subcortically lesioned rats, and its exacerbation in aged rats. J. Neurosci. 15:1995;4896-4905.
349. Walter J., Capell A., Grunberg J., Pesold B., Schindzielorz A., Prior R., Podlisny M. B., Fraser P., Hyslop P. S., Selkoe D. J., Haass C. The Alzheimer's disease-associated presenilins are differentially phosphorylated proteins located predominantly within the enoplasmatic reticulum. Mol. Medicine. 2:1996;673-691.
350. Wasco W., Brook J. D., Tanzi R. E. The amyloid precursor-like protein (APLP) gene maps to the long arm of human chromosom 19. Genomics. 15:1992;237-239.
351. Wasco W., Gurubhagavatula S., Paradis M., Romano D. M., Sisodia S. S., Hyman B. T., Neve R. L., Tanzi R. Isolation and characterization of APLP2 encoding a homologue of the Alzheimer's associated amyloid β protein precursor. Nature Gen. 5:1993;95-100.
352. Watt J. A., Pike C. J., Walancewicz A. J., Cotman C. W. Ultarstructural analysis of β-amyloid-induced apoptosis in cultured hippocampal neurons. Brain Res. 661:1994;147-156.
353. Webster M. T., Groome N., Francis P. T., Pearce B. R., Sherriff F. E., Thinakaran G., Felsenstein K. M., Wasco W., Tanzi R. E., Bowen D. M. A novel protein, amyloid precursor-like protein 2, is present in human brain, cerebrospinal fluid and conditioned media. Biochem. J. 310:1995;95-99.
354. Weidemann A., König G., Bunke D., Fischer P., Salbaum J. M., Masters C., Beyreuther K. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein. Cell. 57:1989;115-126.
355. Wenk G. L., Harrington C. A., Tucker D. A., Rance N. E., Walker L. C. Basal forebrain neurons and memory: a biochemical histological, and behavioral study of differential vulnerability to ibotenate and quisqualate. Behav. Neurosci. 106:1992;909-923.
356. Wenk G. L., Stoehr J. D., Quintana G., Mobley S., Wiley R. G. Behavioral, biochemical, histological, and electrophysiological effects of 192IgG-saporin injections into the basal forebrain of rats. J. Neurosci. 14:1994;5986-5995.
357. Whitehouse P. J., Sing A. K. Cholinergic receptors in aging and Alzheimer's disease. Prog. Neuro-Psychopharmacol. Biol. Psychat. 10:1986;665-676.
358. Whitehouse P. J., Price D. L., Clark A. W., Coyle J. T., DeLong M. R. Alzheimer's disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10:1981;122-126.
359. Whitehouse P. J., Price D. L., Struble R. G., Clark A. W., Coyle J. T., DeLong M. R. Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science. 215:1982;1237-1239.
360. Whitehouse P. J., Struble R. G., Clark A. W., Price D. L. Alzheimer's disease: plaques, tangles, and the basal forebrain. Ann. Neurol. 12:1982;494.
361. Whittemore S. R., Ebendal T., Lärkfors L., Olson L., Seiger A., Strömberg I., Persson H. Developmental and regional expression of β-nerve growth factor messenger RNA and protein in the rat central nervous system. Proc. natl Acad. Sci. U.S.A. 83:1986;817-821.
362. Whittemore S. R., Lärkfors L., Ebendal T., Holets V. R., Ericsson A., Persson H. Increased β-nerve growth factor messenger RNA and protein levels in neonatal rat hippocampus following specific cholinergic lesions. J. Neurosci. 7:1987;244-251.
363. Whittemore S. R., Friedman P. L., Larhammar D., Persson H., Gonzales C. M., Holets V. R. Rat β-nerve growth factor sequence and site of synthesis in the adult hippocampus. J. Neurosci. Res. 20:1988;403-410.
364. Wilcock G. K., Esiri M. M., Bowen D. M., Smith C. C. T. Alzheimer's disease: correlation of cortical choline acetyltransferase actions with the severity of dementia and histological abnormalities. J. Neurol. Sci. 57:1982;407-417.
365. Wildbode C., Yamazaki T., Capell A., Leimer U., Steiner H., Ihara Y., Haass C. Intracellular generation and accumulation of amyloid β peptide terminating at amino acid 42. J. Biol. Chem. 272:1997;16085-16088.
366. Wiley R. G. Neural lesioning with ribosome-inactivating proteins: suicide transport and immunolesioning. Trends Neurosci. 15:1992;285-290.
367. Wiley R. G., Oeltmann T. N., Lappi D. A. Immunolesioning: selective destruction of neurons using immunotoxin to NGF receptor. Brain Res. 562:1991;149-153.
368. Winkler J., Suhr S. T., Gage F. H., Thal L. J., Fisher L. J. Essential role of neocortical acetylcholine in spatial memory. Nature. 375:1995;484-487.
369. Winkler J., Thal L. J. Effects of nerve growth factor treatment on rats with lesions of the nucleus basalis magnocellularis produced by ibotenic acid, quisqualic acid, and AMPA. Exp. Neurol. 136:1995;234-250.
370. Wisniewski T., Frangione B. Apolipoprotein E: a pathologic chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett. 135:1992;235-238.
371. Wolf B. A., Wertkin B. M., Jolly Y. C., Yasuda R. P., Wolfe B. B., Konrad R. J., Manning D., Ravi S., Williamson J. R., Lee V. M. Muscarinic regulation of Alzheimer's disease amyloid precursor protein secretion and amyloid β-protein production in human neuronal NT2N cells. J. Biol. Chem. 270:1995;4916-4922.
372. Wong C. W., Quaranta V., Glenner G. G. Neuritic plaques and cerebrovascular amyloid in Alzheimer's disease are antigenetically related. Proc. natl Acad. Sci. U.S.A. 82:1985;8729-8732.
373. Wood K., Roberts T. M. Oncogenes and protein kinases in neuronal growth-factor action. Bioch. Biophys. Acta. 1155:1993;133-150.
374. Woolf N. J., Gould E., Butcher L. L. Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon. Neuroscience. 30:1989;143-152.
375. Wurtman R. J. Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends Neurosci. 15:1992;117-122.
376. Wyss-Coray T., Masliah E., Mallory M., McConlogue L., Johnson-Wood K., Lin C., Mucke L. Amyloidogenic role of cytokine TGFβ1 in transgenic mice and in Alzheimer's disease. Nature. 389:1997;603-606.
377. Xu H. X., Sweeney D., Wang R., Thinakaran G., Lo A. C. Y., Sisodia S. S., Greengard P., Gandy S. Generation of Alzheimer β-amyloid protein in the trans-Golgi network in the apparent absence of vesicle formation. Proc. natl Acad. Sci. U.S.A. 94:1997;3748-3752.
378. Yaar M., Zhai S., Pilch P. F., Doyle S. M., Eisenhauer P. B., Fine R. E., Gilchrest B. A. Binding of β-amyloid to the p75 neurotrophin receptor induces apoptosis. J. Clin. Invest. 100:1997;2333-2340.
379. Yamada T., Araki E., Izumi R., Goto I., Sasaki H., Sakaki Y. Expression of Alzheimer amyloid-beta protein precursor gene in neuronal cells. Gerontology. 37:1991;24-30.
380. Yamaguchi H., Nakazato Y., Hirai S., Shoji M., Harigaya Y. Electron micrograph of diffuse plaques: initial stage of senile plaque formation in the Alzheimer brain. Am. J. Pathol. 135:1989;593-597.
381. Yankner B. A., Duffy L. K., Kirschner D. A. Neurotrophic and neurotoxic effects of amyloid β protein: reversal by tachykinin neuropeptides. Science. 250:1990;279-286.
382. Yu J., Pizzo D. P., Hutton L. A., Perez-Polo J. R. Role of the cholinergic system in the regulation of neurotrophin synthesis. Brain Res. 705:1995;247-254.
383. Yu J., Wiley R. G., Perez-Polo J. R. Altered NGF protein levels in different brain areas after immunolesion. J. Neurosci. Res. 43:1996;213-223.
384. Zafra F., Hengerer B., Leibrock J., Thoenen H., Lindholm D. Activity dependent regulation of BDNF and NGF mRNA's in the rat hippocampus is mediated by non-NMDA glutamate receptors. EMBO J. 9:1990;3545-3550.
385. Zafra F., Castren E., Thoenen H., Lindholm D. Interplay between glutamate and gamma-aminobutyric acid transmitter systems in the physiological regulation of brain-derived neurotrophic factor and nerve growth factor synthesis in hippocampal neurons. Proc. natl Acad. Sci. U.S.A. 88:1991;10037-10041.